FrancophonIA/ELRC3.0 huggingface dataset:
English: Uncommon: - Paranoia (e.g. excessive fear for one's own well-being) - Delusion - Excessive daytime sleepiness and suddenly falling asleep - Amnesia (memory disturbance)
Danish: Ikke almindelig: - Paranoia (såsom overdreven frygt for sit helbred) - Vrangforestillinger
English: (eating more food than normal and more than is needed to satisfy your hunger)* - Delirium (decreased awareness, confusion, loss of reality)
Danish: - Uhæmmet madindtagelse (spise store mængder mad i en kort periode) eller overdreven madindtagelse (spise mere mad end sædvanligt og mere end nødvendigt for at dække sulten)* - Delirium (nedsat bevidsthed, forvirring, manglende realitetsopfattelse)
English: Oprymea 0.35 mg tablets Each tablet contains 0.35 mg pramipexole (as 0.5 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 0,35 mg tabletter Hver tablet indeholder 0,35 mg pramipexol (som 0,5 mg pramipexoldihydrochloridmonohydrat).
English: IJ
Danish: (mg)
English: Oprymea 0.35 mg tablets Pramipexole
Danish: Oprymea 0,35 mg tabletter Pramipexol
English: Oprymea 0.088 mg tablets Pramipexole
Danish: Oprymea 0,088 mg tabletter Pramipexol
English: Oprymea 1.1 mg tablets Each tablet contains 1.1 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 1,1 mg tabletter Hver tablet indeholder 1,1 mg pramipexol (som 1,5 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 0.26 mg prolonged-release tablets Oprymea 0.52 mg prolonged-release tablets Oprymea 1.05 mg prolonged-release tablets Oprymea 1.57 mg prolonged-release tablets Oprymea 2.1 mg prolonged-release tablets Oprymea 2.62 mg prolonged-release tablets Oprymea 3.15 mg prolonged-release tablets
Danish: Oprymea 0,26 mg depottabletter Oprymea 0,52 mg depottabletter Oprymea 1,05 mg depottabletter Oprymea 1,57 mg depottabletter Oprymea 2,1 mg depottabletter Oprymea 2,62 mg depottabletter Oprymea 3,15 mg depottabletter
English: White, oval, with bevelled edges, both sides scored, with imprint "P7" on both halves of one side of the tablet.
Danish: Hvid, oval, med skrå kanter, delekærv på begge sider og præget med ”P7” på begge halvdele af den ene side af tabletten.
English: Focus Care Pharmaceuticals B.V. Tel: +31 (0)75 612 05 11
Danish: Tel: + 31 (0)75 612 05 11
English: - Hallucinations (seeing, hearing or feeling things that are not there) - Confusion - Excessive daytime sleepiness and suddenly falling asleep - Weight increase - Hypotension (low blood pressure) - Excess of fluid, usually in the legs (peripheral oedema) - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Restlessness - Visual impairment - Weight loss including decreased appetite - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs)* - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Danish: - Unormale, ufrivillige bevægelser (dyskinesi) - Øget muskelaktivitet med ufrivillige bevægelser (hyperkinesi)* - Paranoia (f.eks. overdreven frygt for ens eget helbred)* - Vrangforestillinger* - Hukommelsestab (amnesi)* - Hallucinationer (at se, høre eller føle ting, som ikke er der) - Forvirring - Udtalt træthed om dagen og episoder med pludselig indsættende søvn - Tager på i vægt - Lavt blodtryk (hypotension) - Væskeophobning - hævede fødder, ankler og hænder (perifert ødem) - Allergiske reaktioner (f.eks. udslæt, kløe, overfølsomhed) - Besvimelse - Rastløshed - Synsnedsættelse (dobbeltsyn) - Vægttab samt nedsat appetit - Åndenød (dyspnø) - Hikke - Lungebetændelse* - Manglende evne til at modstå trangen eller fristelsen til at udføre en handling, der kan være skadelig for dig selv eller andre, og som kan omfatte:
English: White, oval, with bevelled edges, both sides scored, with imprint "P8" on both halves of one side of the tablet.
Danish: Hvid, oval, med skrå kanter, delekærv på begge sider og præget med ”P8” på begge halvdele af den ene side af tabletten.
English: 2 tablets Oprymea 0.088 mg three times a day
Danish: 2 tabletter Oprymea 0,088 mg 3 gange om dagen
English: White, round, with bevelled edges, both sides scored, with imprint "P9" on both halves of one side of the tablet.
Danish: Hvid, rund, med skrå kanter, delekærv på begge sider og præget med ”P9” på begge halvdele af den ene side af tabletten.
English: In a Phase I trial, where pramipexole immediate release and prolonged-release tablets were assessed in fasted state, the minimum and peak plasma concentration (Cmin, Cmax) and exposure (AUC) of the same daily dose of pramipexole prolonged-release tablets given once daily and pramipexole tablets given three times a day were equivalent.
Danish: Et fase-I studie, hvor pramipexoltabletter blev sammenlignet med pramipexoldepottabletter, viste ækvivalens mellem den samme døgndosis af pramipexol depottabletter givet en gang daglig og pramipexol tabletter givet 3 gange daglig for Cmin, Cmax og AUC.
English: However, it should be noted that the incidence of somnolence is increased at doses higher than 1.5 mg (of salt) per day (see section 4.8).
Danish: Man skal være opmærksom på, at hyppigheden af døsighed øges ved doser højere end 1,5 mg (salt)/dag (se pkt.
English: What Oprymea is and what it is used for What you need to know before you take Oprymea How to take Oprymea
Danish: Det skal du vide, før du begynder at tage Oprymea Sådan skal du tage Oprymea Bivirkninger
English: Oprymea 3.15 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P5 on one side and 315 on the other side, with bevelled edges and possible spots.
Danish: Oprymea med 3,15 mg depottabletter er hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P5 på den ene side og med 315 på den anden side, med skrå kanter og muligvis plettede.
English: During dose escalation in pivotal studies, efficacy was observed starting at a daily dose of 1.05 mg of base (1.5 mg of salt).
Danish: I kliniske titreringsforsøg sås en virkning allerede ved en daglig dosis på 1,05 mg base (1,5 mg salt).
English: Oprymea 0.7 mg tablets Pramipexole
Danish: Oprymea 0,7 mg tabletter Pramipexol
English: Each tablet contains 0.088 mg pramipexole (as 0.125 mg pramipexole dihydrochloride monohydrate).
Danish: Hver tablet indeholder 0,088 mg pramipexol (som 0,125 mg pramipexoldihydrochloridmonohydrat).
English: Rare may affect up to 1 in 1,000 people
Danish: Sjælden til <1/1.000)
English: Superiority of pramipexole prolonged-release tablets over placebo was demonstrated after 18 weeks of treatment on both the primary (UPDRS Parts II+III score) and the key secondary (CGI-I and PGI-I responder rates) efficacy endpoints in a double-blind placebo-controlled trial including a total of 539 patients with early Parkinson's disease.
Danish: Et dobbeltblindet, placebokontrolleret studie med 539 patienter med tidlig Parkinsons sygdom viste, at pramipexol depottabletter havde en bedre virkning (superior) end placebo efter 18 ugers behandling på både det primære (UPDRS del II+III score) og vigtigste sekundære (CGI-I og PGI-I responderhastigheder) endepunkter.
English: - 7 prolonged-release tablets of 0.52 mg
Danish: - 7 depottabletter indeholdende 0,52 mg
English: Oprymea 0.18 mg tablets Each tablet contains 0.18 mg pramipexole (as 0.25 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 0,18 mg tabletter Hver tablet indeholder 0,18 mg pramipexol (som 0,25 mg pramipexoldihydrochloridmonohydrat).
English: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P13 on one side and 262 on the other side, with bevelled edges and possible spots.
Danish: Hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P13 på den ene side og med 262 på den anden side, med skrå kanter og muligvis plettede.
English: Oprymea 2.62 mg prolonged-release tablets Pramipexole
Danish: Oprymea 2,62 mg depottabletter Pramipexol
English: Oprymea 0.7 mg tablets Each tablet contains 0.7 mg pramipexole (as 1 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 0,7 mg tabletter Hver tablet indeholder 0,7 mg pramipexol (som 1 mg pramipexoldihydrochloridmonohydrat).
English: - Hyperkinesia (increased movements and inability to keep still) - Weight increase - Allergic reactions (e.g. rash, itching, hypersensitivity) - Fainting - Cardiac failure (heart problems which can cause shortness of breath or ankle swelling)* - Inappropriate antidiuretic hormone secretion* - Restlessness - Dyspnoea (difficulties to breathe) - Hiccups - Pneumonia (infection of the lungs) - Inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:
Danish: - Udtalt træthed om dagen og episoder med pludselig indsættende søvn - Hukommelsestab (amnesi) Øget muskelaktivitet med ufrivillige (hyperkinesi) - Vægtforøgelse - Allergiske reaktioner (f.eks. udslæt, kløe, overfølsomhed) - Besvimelse - Hjertesvigt (hjerteproblemer, der kan forårsage åndenød eller hævede ankler)* - Uhensigtsmæssig udskillelse af antidiuretisk hormon - Rastløshed - Åndenød (dyspnø) - Hikke - Lungebetændelse - Manglende evne til at modstå trangen eller fristelsen til at udføre en handling, der kan være skadelig for dig selv eller andre, og som kan omfatte: - Stærk trang til at spille (sygelig spilletrang) trods alvorlige personlige og familiemæssige konsekvenser.
English: Gastrointestinal disorders nausea constipation vomiting
Danish: Mave-tarm-kanalen kvalme forstoppelse, opkastning
English: 1 tablet Oprymea 0.088 mg three times a day
Danish: 1 tablet Oprymea 0,088 mg 3 gange om dagen
English: Oprymea 0.18 mg tablets Pramipexole
Danish: Oprymea 0,18 mg tabletter Pramipexol
English: If you experience these side effects, you must not drive or operate machinery.
Danish: Du skal afstå fra at køre bil, motorcykel, eller cykel, og lade være med at arbejde med værktøj eller maskiner, hvis du oplever disse bivirkninger.
English: 4 tablets Oprymea 0.088 mg
Danish: 4 tabletter Oprymea 0,088 mg
English: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P5 on one side and 315 on the other side, with bevelled edges and possible spots.
Danish: Hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P5 på den ene side og med 315 på den anden side, med skrå kanter og muligvis plettede.
English: Take Oprymea prolonged-release tablets only once a day and each day at about the same time.
Danish: Oprymea depottabletter skal tages en gang daglig.
English: 2 tablets Oprymea 0.088 mg
Danish: 2 tabletter Oprymea 0,088 mg
English: 6 tablets Oprymea 0.088 mg
Danish: 6 tabletter Oprymea 0,088 mg
English: 3 tablets Oprymea 0.18 mg OR
Danish: 3 tabletter Oprymea 0,18 mg
English: Please tell your doctor if this occurs.
Danish: Tal med din læge.
English: Oprymea 0.26 mg Oprymea 0.52 mg Oprymea 1.05 mg prolonged-release tablets
Danish: Oprymea 0,26 mg Oprymea 0,52 mg Oprymea 1,05 mg depottabletter
English: 1 tablet Oprymea 0.18 mg OR
Danish: 1 tablet Oprymea 0,18 mg
English: Each prolonged-release tablet contains 2.62 mg pramipexole (as 3.75 mg pramipexole dihydrochloride monohydrate).
Danish: Hver depottablet indeholder 2,62 mg pramipexol (som 3,75 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 1.05 mg: Each prolonged-release tablet contains 1.05 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 1,05 mg: Hver depottablet indeholder 1,05 mg pramipexol (som 1,5 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 0.26 mg Oprymea 0.52 mg Oprymea 1.05 mg prolonged-release tablets Pramipexole
Danish: Oprymea 0,26 mg Oprymea 0,52 mg Oprymea 1,05 mg depottabletter Pramipexol
English: 1 tablet Oprymea 0.18 mg three times a day OR
Danish: 1 tablet Oprymea 0,18 mg 3 gange om dagen
English: If you have advanced Parkinson's disease and are also taking levodopa, you might develop dyskinesia during the uptitration of Oprymea - Dystonia (inability of keeping your body and neck straight and upright (axial dystonia)).
Danish: Hvis du har Parkinsons sygdom i fremskreden grad og samtidig behandles med levodopa, kan der være risiko for udvikling af ufrivillige bevægelser (dyskinesi), når Oprymea-dosis øges.
English: Oprymea 2.62 mg prolonged-release tablets
Danish: Oprymea 2,62 mg depottabletter
English: 1.05 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P3 on one side, with bevelled edges and possible spots.
Danish: 1,05 mg: Hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P3 på den ene side, med skrå kanter og muligvis plettede.
English: A sudden stop could cause you to develop a medical condition called neuroleptic malignant syndrome which may represent a major health risk.
Danish: Hvis du har Parkinsons sygdom, bør du ikke stoppe behandlingen med Oprymea pludseligt, da det kan medføre en sygelig tilstand, der udgør en alvorlig helbredsrisiko (malignt neuroleptika syndrom).
English: Each tablet contains 0.35 mg pramipexole (as 0.5 mg pramipexole dihydrochloride monohydrate).
Danish: Hver tablet indeholder 0,35 mg pramipexol (som 0,5 mg pramipexoldihydrochloridmonohydrat).
English: 0.26 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P1 on one side, with bevelled edges and possible spots.
Danish: 0,26 mg: Hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P1 på den ene side, med skrå kanter og muligvis plettede.
English: Each tablet contains 1.1 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Danish: Hver tablet indeholder 1,1 mg pramipexol (som 1,5 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 0.26 mg: Each prolonged-release tablet contains 0.26 mg pramipexole (as 0.375 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 0,26 mg: Hver depottablet indeholder 0,26 mg pramipexol (som 0,375 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 0.52 mg: Each prolonged-release tablet contains 0.52 mg pramipexole (as 0.75 mg pramipexole dihydrochloride monohydrate).
Danish: Oprymea 0,52 mg: Hver depottablet indeholder 0,52 mg pramipexol (som 0,75 mg pramipexoldihydrochloridmonohydrat).
English: Each tablet contains 0.7 mg pramipexole (as 1 mg pramipexole dihydrochloride monohydrate).
Danish: Hver tablet indeholder 0,7 mg pramipexol (som 1 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 0.35 mg tablets 20 tablets: EU/1/08/469/011 30 tablets: EU/1/08/469/012 60 tablets: EU/1/08/469/013 90 tablets: EU/1/08/469/014 100 tablets: EU/1/08/469/015
Danish: Oprymea 0,35 mg tabletter 20 tabletter: EU/1/08/469/011 30 tabletter: EU/1/08/469/012 60 tabletter: EU/1/08/469/013 90 tabletter: EU/1/08/469/014 100 tabletter: EU/1/08/469/015
English: The tablets may be taken either with or without food and should be taken each day at about the same time.
Danish: Tabletterne kan både tages sammen med mad og alene.
English: Oprymea 1.1 mg tablets 20 tablets: EU/1/08/469/021 30 tablets: EU/1/08/469/022 60 tablets: EU/1/08/469/023 90 tablets: EU/1/08/469/024 100 tablets: EU/1/08/469/025
Danish: Oprymea 1,1 mg tabletter 20 tabletter: EU/1/08/469/021 30 tabletter: EU/1/08/469/022 60 tabletter: EU/1/08/469/023 90 tabletter: EU/1/08/469/024 100 tabletter: EU/1/08/469/025
English: Each prolonged-release tablet contains 3.15 mg pramipexole (as 4.5 mg pramipexole dihydrochloride monohydrate).
Danish: Hver depottablet indeholder 3,15 mg pramipexol (som 4,5 mg pramipexoldihydrochloridmonohydrat).
English: Each prolonged-release tablet contains 1.57 mg pramipexole (as 2.25 mg pramipexole dihydrochloride monohydrate).
Danish: Hver depottablet indeholder 1,57 mg pramipexol (som 2,25 mg pramipexoldihydrochloridmonohydrat).
English: Doses should be increased gradually from a starting-dose of 0.264 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days.
Danish: Dosis skal øges gradvist hver 5.-7. dag fra en startdosis på 0,264 mg base (0,375 mg salt)/døgn.
English: The individual dose of pramipexole should be in the range of 0.26 mg of base (0.375 mg of salt) to a maximum of 3.15 mg of base (4.5 mg of salt) per day.
Danish: Den daglige dosis bør være mellem 0,26 mg base (0,375 mg salt) og 3,15 mg base (4,5 mg salt).
English: 0.52 mg: White or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P2 on one side, with bevelled edges and possible spots.
Danish: 0,52 mg: Hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P2 på den ene side, med skrå kanter og muligvis plettede.
English: Oprymea 3.15 mg prolonged-release tablets
Danish: Oprymea 3,15 mg depottabletter
English: Oprymea 3.15 mg prolonged-release tablets Pramipexole
Danish: Oprymea 3,15 mg depottabletter Pramipexol
English: Each tablet contains 0.18 mg pramipexole (as 0.25 mg pramipexole dihydrochloride monohydrate).
Danish: Hver tablet indeholder 0,18 mg pramipexol (som 0,25 mg pramipexoldihydrochloridmonohydrat).
English: Each prolonged-release tablet contains 2.1 mg pramipexole (as 3 mg pramipexole dihydrochloride monohydrate).
Danish: Hver depottablet indeholder 2,1 mg pramipexol (som 3 mg pramipexoldihydrochloridmonohydrat).
English: EU/1/08/469/011 [20 tablets] EU/1/08/469/012 [30 tablets] EU/1/08/469/013 [60 tablets] EU/1/08/469/014 [90 tablets] EU/1/08/469/015 [100 tablets]
Danish: EU/1/08/469/011 [20 tabletter] EU/1/08/469/012 [30 tabletter] EU/1/08/469/013 [60 tabletter] EU/1/08/469/014 [90 tabletter] EU/1/08/469/015 [100 tabletter]
English: What Oprymea looks like and contents of the pack Oprymea 0.088 mg tablets are white, round, with bevelled edges and imprint "P6" on one side of the tablet.
Danish: Oprymea 0,088 mg tabletter er hvide, runde, med skrå kanter og præget med ”P6” på den ene side af tabletten.
English: EU/1/08/469/021 [20 tablets] EU/1/08/469/022 [30 tablets] EU/1/08/469/023 [60 tablets] EU/1/08/469/024 [90 tablets] EU/1/08/469/025 [100 tablets]
Danish: EU/1/08/469/021 [20 tabletter] EU/1/08/469/022 [30 tabletter] EU/1/08/469/023 [60 tabletter] EU/1/08/469/024 [90 tabletter] EU/1/08/469/025 [100 tabletter]
English: Oprymea 0.18 mg tablets 20 tablets: EU/1/08/469/006 30 tablets: EU/1/08/469/007 60 tablets: EU/1/08/469/008 90 tablets: EU/1/08/469/009 100 tablets: EU/1/08/469/010
Danish: Oprymea 0,18 mg tabletter 20 tabletter: EU/1/08/469/006 30 tabletter: EU/1/08/469/007 60 tabletter: EU/1/08/469/008 90 tabletter: EU/1/08/469/009 100 tabletter: EU/1/08/469/010
English: Each prolonged-release tablet contains 1.05 mg pramipexole (as 1.5 mg pramipexole dihydrochloride monohydrate).
Danish: Hver depottablet indeholder 1,05 mg pramipexol (som 1,5 mg pramipexoldihydrochloridmonohydrat).
English: Oprymea 1.05 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P3 on one side, with bevelled edges and possible spots.
Danish: Oprymea med 1,05 mg depottabletter er hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P3 på den ene side, med skrå kanter og muligvis plettede.
English: Oprymea is used to treat the symptoms of primary Parkinson's disease in adults.
Danish: Oprymea er indiceret til voksne til behandling af tegn og symptomer på idiopatisk Parkinsons sygdom.
English: Oprymea 1.57 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P12 on one side, with bevelled edges and possible spots.
Danish: Oprymea med 1,57 mg depottabletter er hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P12 på den ene side, med skrå kanter og muligvis plettede.
English: Doses should be increased gradually from a starting dose of 0.26 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days.
Danish: Dosis skal øges gradvist hver 5.-7. dag fra en startdosis på 0,26 mg base (0,375 mg salt)/døgn.
English: Oprymea 0.7 mg tablets 20 tablets: EU/1/08/469/016 30 tablets: EU/1/08/469/017 60 tablets: EU/1/08/469/018 90 tablets: EU/1/08/469/019 100 tablets: EU/1/08/469/020
Danish: Oprymea 0,7 mg tabletter 20 tabletter: EU/1/08/469/016 30 tabletter: EU/1/08/469/017 60 tabletter: EU/1/08/469/018 90 tabletter: EU/1/08/469/019 100 tabletter: EU/1/08/469/020
English: Oprymea 0.52 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P2 on one side, with bevelled edges and possible spots.
Danish: Oprymea med 0,52 mg depottabletter er hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P2 på den ene side, med skrå kanter og muligvis plettede.
English: Oprymea 3.15 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/050 30 prolonged-release tablets: EU/1/08/469/051 90 prolonged-release tablets: EU/1/08/469/052 100 prolonged-release tablets: EU/1/08/469/053
Danish: Oprymea 3,15 mg depottabletter 10 depottabletter: EU/1/08/469/050 30 depottabletter: EU/1/08/469/051 90 depottabletter: EU/1/08/469/052 100 depottabletter: EU/1/08/469/053
English: Oprymea 1.05 mg prolonged-release tablets
Danish: Oprymea 1,05 mg depottabletter
English: When prescribing Oprymea in a patient with Parkinson's disease with renal impairment a reduced dose is suggested in line with section 4.2.
Danish: Hos patienter med Parkinsons sygdom og nedsat nyrefunktion bør dosis reduceres, se pkt.
English: Oprymea 1.05 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/034 30 prolonged-release tablets: EU/1/08/469/035 90 prolonged-release tablets: EU/1/08/469/036 100 prolonged-release tablets: EU/1/08/469/037
Danish: Oprymea 1,05 mg depottabletter 10 depottabletter: EU/1/08/469/034 30 depottabletter: EU/1/08/469/035 90 depottabletter: EU/1/08/469/036 100 depottabletter: EU/1/08/469/037
English: Oprymea 2.1 mg prolonged-release tablets are white or almost white, round (diameter 10 mm), slightly biconvex tablets engraved with P4 on one side, with bevelled edges and possible spots.
Danish: Oprymea med 2,1 mg depottabletter er hvide til næsten hvide, runde (10 mm i diameter), let hvælvede tabletter, præget med P4 på den ene side, med skrå kanter og muligvis plettede.
English: Ascending - Dose Schedule of Oprymea Week
Danish: Skema for dosisøgning af Oprymea
English: Oprymea 2.1 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/042 30 prolonged-release tablets: EU/1/08/469/043 90 prolonged-release tablets: EU/1/08/469/044 100 prolonged-release tablets: EU/1/08/469/045
Danish: Oprymea 2,1 mg depottabletter 10 depottabletter: EU/1/08/469/042 30 depottabletter: EU/1/08/469/043 90 depottabletter: EU/1/08/469/044 100 depottabletter: EU/1/08/469/045
English: EU/1/08/469/001[20 tablets] EU/1/08/469/002 [30 tablets] EU/1/08/469/003 [60 tablets] EU/1/08/469/004 [90 tablets] EU/1/08/469/005 [100 tablets]
Danish: EU/1/08/469/001 [20 tabletter] EU/1/08/469/002 [30 tabletter] EU/1/08/469/003 [60 tabletter] EU/1/08/469/004 [90 tabletter] EU/1/08/469/005 [100 tabletter]
English: EU/1/08/469/016 [20 tablets] EU/1/08/469/017 [30 tablets] EU/1/08/469/018 [60 tablets] EU/1/08/469/019 [90 tablets] EU/1/08/469/020 [100 tablets]
Danish: EU/1/08/469/016 [20 tabletter] EU/1/08/469/017 [30 tabletter] EU/1/08/469/018 [60 tabletter] EU/1/08/469/019 [90 tabletter] EU/1/08/469/020 [100 tabletter]
English: Oprymea 2.62 mg prolonged-release tablets 10 prolonged-release tablets: EU/1/08/469/046 30 prolonged-release tablets: EU/1/08/469/047 90 prolonged-release tablets: EU/1/08/469/048 100 prolonged-release tablets: EU/1/08/469/049
Danish: Oprymea 2,62 mg depottabletter 10 depottabletter: EU/1/08/469/046 30 depottabletter: EU/1/08/469/047 90 depottabletter: EU/1/08/469/048 100 depottabletter: EU/1/08/469/049
English: EU/1/08/469/042 [10 prolonged-release tablets] EU/1/08/469/043 [30 prolonged-release tablets] EU/1/08/469/044 [90 prolonged-release tablets] EU/1/08/469/045 [100 prolonged-release tablets]
Danish: EU/1/08/469/042 [10 depottabletter] EU/1/08/469/043 [30 depottabletter] EU/1/08/469/044 [90 depottabletter] EU/1/08/469/045 [100 depottabletter]